FIELD: pharmacology.
SUBSTANCE: method comprises oral administration of a dosage form containing a pharmacologically active agent according to the general formula 
wherein R is -H or -CH3, or a physiologically acceptable salt thereof, once a day, to a subject in need thereof. The dosage form provides immediate in vitro release of the pharmacologically active agent, which is contained in a dose of 40 to 190 μg, and the pharmacokinetic parameter tmax is in the range of 4 to 6 hours.
EFFECT: good bioavailability and sufficiency of pain relief, high tolerability and safety.
12 cl, 5 dwg, 15 tbl, 3 ex
| Title |
Year |
Author |
Number |
| DOSED DRUG FORM CONTAINING 6-FLUORO-(N-METHYL- OR N,N-DIMETHYL-)-4-PHENYL-4', 9'-DIHYDRO-3'N-SPIRO[CYCLOHEXANE-1,1'-PYRANO[3,4,INDOLE]-4-AMINE FOR NOCICEPTIVE PAIN TREATMENT |
2011 |
- Gryuning Nadya
- Shiller Mark
- Fridrikh Ingo
- Kerbi Kris
- Khemani Ashish
- Botmer Jokhn
- Sholts Andreas
|
RU2631481C2 |
| DRUG DOSAGE FORM CONTAINING 6'-FLUORO-(N-METHYL- OR N, N-DIMETHYL-)-4-PHENYL-4', 9'-DIHYDRO-3'H-SPIRO[CYCLOHEXANE-1, 1'-PYRANO[3, 4, b]INDOLE]-4-AMINE |
2011 |
- Shiller Mark
- Gryuning Nadya
- Khemani Ashish
|
RU2589831C2 |
| DRUG DOSAGE FORM CONTAINING 6'-FLUORO-(N-METHYL-OR N, N-DIMETHYL-)-4-PHENYL-4',9'-DIHYDRO-3'H-SPIRO[CYCLOHEXANE-1, 1'-PYRANO[3, 4, b]INDOLE]-4-AMINE |
2011 |
- Gryuning Nadya
- Shiller Mark
|
RU2589830C2 |
| MEDICINAL DOSAGE FORM, WHICH CONTAINS 6'-FLUOR-(N-METHYL-OR N,N-DIMETHYL)-4-PHENYL-4',9'-DIHYDRO-3'H-SPIRO[CYCLOHEXANE-1,1'-PYRANO[3,4,b]INDOLE]-4-AMINE |
2011 |
- Shiller Mark
- Grjuning Nadja
- Fridrikh Ingo
- Kerbi Kris
|
RU2582390C2 |
| DERIVATIVES OF CIS-TETRAHYDRO-SPIRO(CYCLOHEXANE-1,1'-PYRIDO[3,4-b]INDOLE)-4-AMINE EFFECTIVE IN TREATING NEUROPATHIC AND/OR CHRONIC PAIN |
2011 |
- Lints Klaus
- Tsemolka Zaskia
- Nolte Bert
- Shunk Shtefan
- Shik Khans
|
RU2592283C2 |
| COMPOSITION COMPRISING N-{5-[4-(4-METHYLPIPERAZINOMETHYL)BENZOYLAMIDO]-2-METHYLPHENYL}-4-(3-PYRILYL)-2-PYRIDINEAMINE AND CHEMOTHERAPEURIC AGENT |
2002 |
- Bruns Kristian
- Bukhdunger Ehlizabet
- O`Rejlli Terens
- Silberman Sandra Lita
- Vartmann Markus
- Vekkbekker Gizbert
|
RU2318517C2 |
| ESLICARBAZEPINE ACETATE AND METHODS FOR APPLYING THEREOF |
2005 |
- V'Ejra Arauzhu Suarish Da Silva Patrisio Manuehl
- De Almejda Zhoze Luish
|
RU2417085C2 |
| SALTS OF 1-(4-(2-((1-(3,4-DIFLUOROPHENYL)-1N-PYRAZOL-3-YL)METHOXY)ETHYL)PIPERAZIN-1-YL)ETHANONE |
2016 |
- Torrens-Jover Antoni
- Almansa Rosales Carmen
|
RU2727974C2 |
| METHOD OF TREATING NEUROPATHIC PAIN AND ASSOCIATED WITH IT SYNDROMES |
2005 |
- Dzhonson Kirk V.
- Zul'Tsbaf Lehns
- Shumilla Dzhennifer
|
RU2433825C2 |
| DELAYED-RELEASE ORAL DOSAGE FORM OF GABAPENTIN |
2005 |
- Kandi Kennet K.
- Sastri Srikonda
- Leung Mansh'Ju
- Kadri Baladzhi V.
- Stehch Pol Eh.
|
RU2440112C2 |
